Sutter Health Research Enterprise
2850 Telegraph Ave
Suite 110
Berkeley, CA, 94705
(510) 204-8140
jehlel@sutterhealth.org
Primary Research Interests
Related Clinical Trials
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progr
Investigators: Matthew W. Arnold M.D., David Eric Collins MD, Joanna A. Cooper M.D., Aryn Earnhardt NP, Lynn Jehle NP, Antonio J Silva-Sayago MD, Bradley T Wrubel MD
Status: Active, Recruiting